Cardiac output is determined, in large part, by the venous return of blood to the heart. Various adrenergic and pharmacologic influences affect venous return. In the dog it appears that the liver may play an important role in the control of blood flow from the splanchnic to the central circulation and, hence, in the control of venous return.
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Circulating Catecholomines oSympathetic Innervation FIG. 1. A schematic representation of the control of the systemic venous system [2] . See text for details.
amines may influence the capacity of the skeletal muscle venous system, sympathetic neural control of the venous system in this area is minimal [2] . The venous system of the skin can respond to sympathetic innervation and circulating substances, but this latter system is a relatively small reservoir consisting of only several hundred milliliters of blood [2] . The splanchnic circulation, however, is a rather extensive blood reservoir. In man, approximately one-fifth of the total blood volume resides within the splanchnic venous bed [2] . The areas within the splanchnic circulation which constitute this blood reservoir include the spleen, the mesenteric vasculature, and the sinusoids of the liver. The spleen has the potential of decreasing in size sufficiently to release as much as one-third of the splanchnic venous volume of blood into the remainder of the circulation [4] . The venous system of the mesenteric vasculature can contribute between one-third and one-half of the splanchnic volume to the central blood volume [4] . Lastly, the sinusoids of the liver are capable of releasing the remainder of the splanchnic blood volume into the rest of the circulation [4] . Thus, the splanchnic circulation has the capability of augmenting the central blood volume within the vena cava, the heart, and the lungs by 600-700 ml and is of great potential importance in the regulation of venous return in man.
It has been thought that the major mechanism of control of blood volume within the splanchnic circulation consists of an action directly on blood vessels by sympathetic innervation and circulating substances such as catecholamines [2] . A decrease in systemic arterial pressure is accompanied by a decrease in the inhibitory influences of the baroreceptors of the carotid sinus and aortic area on the vasomotor center and a resulting increase in sympathetic outflow. An increase in sympathetic stimuli results in a constriction of venous smooth muscle and mobilization of blood from the splanchnic vasculature toward the heart.
It has been established that alpha adrenergic receptor stimulation, whether secondary to increased sympathetic nerve activity or to circulating catecholamines, results in constriction of veins of numerous organ systems, including skin, skeletal muscle, and the kidney [2, [5] [6] [7] [8] [9] [10] . Alexander [11] It is likely that the venoconstrictor effects of alpha adrenergic receptor stimulation on both the splanchnic and the remainder of the peripheral vasculature, exclusive of the heart, contributed to the increase in venous return noted by Kaiser, Ross, and Braunwald [6] when they administered phenylephrine to the dog on total cardiopulmonary bypass. However, in addition, this latter study demonstrated that beta adrenergic receptor stimulation by isoproterenol also resulted in an increase in venous return. This increase in venous return to the central circulation was blocked by pronethalol (Nethalide R ), one of the first beta adrenergic receptor blocking drugs. In vivo studies of the effects of isoproterenol have clearly demonstrated the dilator properties of the drug in cutaneous veins, the femoral vein, and the vena cava through beta adrenergic receptor activation [15] . As recently reviewed by Shepherd and Vanhoutte [5] in isolated veins isoproterenol depresses spontaneous activity and depresses the responses to nerve stimulation or to vasoconstrictor drugs such as alpha adrenergic agonists. Both in the intact organism and in the organ bath, the venodilator action of isoproterenol is specifically counteracted by drugs known to block beta adrenergic receptors [5] . This venodilation should pool blood peripherally and not increase venous return to the heart as found by Kaiser et al. [6] . While it is true that very high doses of isoproterenol can cause alpha adrenergic receptor activation and contraction of isolated helical strips of canine saphenous veins, the concentration of isoproterenol necessary to produce this effect is 1 x 10-5 g/ml [14] . This concentration is at least 40 times that achieved by Kaiser et al. [6] .
Thus, in the experiments by Kaiser, Ross, and Braunwald [6] , the question remains as to the mechanism whereby beta adrenergic receptor stimulation with isoproterenol caused an increase in venous return. The recent work of Green [17, 18] again confirms the finding of an increase in venous return caused by isoproterenol and postulates a possible mechanism whereby venodilatation by this agent might increase venous return to the heart. Using an experimental dog model [19] , Green developed evidence for the existence of an ".effective splanchnic back pressure." In these experiments, which employed a right heart bypass preparation, Green demonstrated that elevations of hepatic venous pressure produce no change in splanchnic blood flow or portal pressure until hepatic venous pressure is raised to a critical value. As hepatic venous pressure is raised above this value, portal pressure rises and splanchnic flow falls. This critical value of hepatic venous pressure is therefore considered to be the "effective splanchnic back pressure" under conditions in which hepatic venous pressure is less than this value. Green's experiments [19] have demonstrated that the effective splanchnic back pressure generates volume in the splanchnic bed. Green noted [ 18] that isoproterenol reduced hepatic vascular resistance as determined by measurements of "effective splanchnic back pressure." Therefore, Green postulated that the increase in venous return produced by isoproterenol can be wholly or partially accounted for by a release in splanchnic blood volume caused by a reduction in the effective splanchnic back pressure. Thus, it is possible that the liver may, through changes in resistance to splanchnic outflow, act like a "sphincter" which can regulate the transfer of blood volume from the relatively high pressure system in the portal circulation to the central venous circulation. This concept is illustrated schematically in Fig. 2 our preliminary experiments [20] [5, 15] with the displacement of blood from the whole animal [6, 16, 17] . This mechanism of diminishing transhepatic vascular resistance may be of major importance in the regulation of venous capacity. [26] .
Our preliminary unpublished observa-tions suggest that the increase in canine transhepatic resistance and the increase in portal vein pressure associated with ouabain (a digitalis glycoside) administration is, at least in part, mediated through alpha adrenergic receptor stimulation. The magnitude of either dilation or constriction of a transhepatic "sphincter" may be importantly related to the control level of transhepatic resistance to portal blood flow. In our experiments on the effects of isoproterenol and norepinephrine mentioned above, the control levels of portal pressure were elevated for the dog [20] , and therefore the absolute volume of blood displaced centrally with beta adrenergic receptor stimulation may have been greater than under conditions of an initially normal portal pressure. Explanations for the elevation of portal pressure should include the possibility of endotoxin release, which is known to elevate portal pressure in the dog [27] . This release of endotoxin may have occurred during the extensive surgical manipulation necessary to set up the preparation. However, the study on the effects of vasopressin cited below [28] demonstrates that it is also possible to lower substantially transhepatic resistance to blood flow when portal pressure is initially normal (7.2 ± 1 mm Hg).
A recently published study [28] on the effects of vasopressin on canine hepatic hemodynamics helps to localize the site of control of transhepatic resistance. The results from this study demonstrate that infusions of vasopressin into either the hepatic artery or the portal vein elicit hepatic venous dilation and a quantitatively similar decrease in portal vascular resistance. This suggests that these alterations in portal vascular resistance were due to effects on a common outlet resistance site. Thus, it appears that in addition to increasing arterial resistance and thereby decreasing inflow to the mesenteric circulation [28] , vasopressin also reduces the resistance to portal blood flow at a site which is likely to be at or beyond the outlets of the hepatic sinusoids into the hepatic venules. These data, obtained in a different laboratory, support the concept of the existence of a hepatic venous "sphincter" which is of importance in regulating portal vein hemodynamics.
Hepatic venous sphincters are thought to be present in several animal species, including the dog [29] [30] [31] . Possible anatomic locations for the sphincters include the junctions of the hepatic veins with the inferior vena cava [32] , the sublobular hepatic veins [33] , and the hepatic sinusoids [34] . Alternatively, it is possible that the entire hepatic venous system may vasoconstrict [35, 36] .
In man, Popper [37] described the junctions of central venules with hepatic veins as being "funnel-like." Elias and Popper [38] noted that thin-walled hepatic venules in the human constricted on entering a thick-walled vessel. In neoprene casts of the hepatic venous system in man made by Gibson [39] , the junctions of central venules and hepatic veins were sometimes retracted. Since the junctions were numerous, Gibson concluded that junctional constriction was probably the "chief venous sphincter mechanism in the human liver." Krogh and Lindhard [40] demonstrated that the human liver and portal vein bed could store and release blood and thereby control the rate of filling of the heart and thus cardiac output. These data have been interpreted by Knisely et al. [34] as indicating that the control of the outflow of blood from livers of healthy humans is an important factor in the control of cardiac output. Thus, it appears likely that the data obtained using the dog model will be at least directionally similar to those in man, but the extent to which post-sinusoidal resistance regulates transhepatic blood flow in the human remains to be documented. 
